rs755863167
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_004213.5(SLC28A1):c.40C>G(p.Leu14Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000013 in 1,614,072 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_004213.5 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC28A1 | ENST00000394573.6 | c.40C>G | p.Leu14Val | missense_variant | Exon 3 of 19 | 1 | NM_004213.5 | ENSP00000378074.1 | ||
SLC28A1 | ENST00000286749.3 | c.40C>G | p.Leu14Val | missense_variant | Exon 2 of 18 | 1 | ENSP00000286749.3 | |||
SLC28A1 | ENST00000338602.6 | c.40C>G | p.Leu14Val | missense_variant | Exon 3 of 7 | 1 | ENSP00000341629.2 | |||
SLC28A1 | ENST00000538177.5 | c.40C>G | p.Leu14Val | missense_variant | Exon 2 of 15 | 2 | ENSP00000443752.1 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152224Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00000795 AC: 2AN: 251480 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.00000342 AC: 5AN: 1461848Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 727234 show subpopulations
GnomAD4 genome AF: 0.000105 AC: 16AN: 152224Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74364 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.40C>G (p.L14V) alteration is located in exon 3 (coding exon 1) of the SLC28A1 gene. This alteration results from a C to G substitution at nucleotide position 40, causing the leucine (L) at amino acid position 14 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at